Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening

by Peter H Scanlon, Stephen J Aldington, Jose Leal, Ramon Luengo-Fernandez, Jason Oke, Sobha Sivaprasad, Anastasios Gazis, Irene M Stratton
Published 2015-09-01

The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial

by Cristina Hernández, Massimo Porta, Francesco Bandello, Jakob Grauslund, Simon P. Harding, Stephen J. Aldington, Catherine Egan, Ulrik Frydkjaer-Olsen, José García-Arumí, Jonathan Gibson, Gabriele E. Lang, Rosangela Lattanzio, Pascale Massin, Edoardo Midena, Berta Ponsati, Luísa Ribeiro, Peter Scanlon, José Cunha-Vaz, Rafael Simó
Published 2020-04-01